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Abstract
Background: Our previous study suggested that licorice has anti-inflammatory activity in lipopolysaccharide-
stimulated microglial cells and anti-oxidative activity in tert-butyl hydroperoxide–induced oxidative liver damage. In
this study, we evaluated the effect of licorice on chronic alcohol-induced fatty liver injury mediated by
inflammation and oxidative stress.
Methods: Raw licorice was extracted, and quantitative and qualitative analysis of its components was performed by
using LC–MS/MS. Mice were fed a liquid alcohol diet with or without licorice for 4 weeks.
Results: We have standardized 70 % fermented ethanol extracted licorice and confirmed by LC-MS/MS as glycyrrhizic
acid (GA), 15.77 ± 0.34 μg/mg; liquiritin (LQ), 14.55 ± 0.42 μg/mg; and liquiritigenin (LG), 1.34 ± 0.02 μg/mg, respectively.
Alcohol consumption increased serum alanine aminotransferase and aspartate aminotransferase activities and the
levels of triglycerides and tumor necrosis factor (TNF)-α. Lipid accumulation in the liver was also markedly induced,
whereas the glutathione level was reduced. All these alcohol-induced changes were effectively inhibited by licorice
treatment. In particular, the hepatic glutathione level was restored and alcohol-induced TNF-α production was
significantly inhibited by licorice.
Conclusion: Taken together, our data suggests that protective effect of licorice against alcohol-induced liver injury
may be attributed to its anti-inflammatory activity and enhancement of antioxidant defense.
Keywords: Licorice, Alcohol-induced liver injury, Glutathione, TNF-α
Background
Licorice is the root of Glycyrriza uralensis Fischer, Gly-
cyrrhiza glabra Linné or Glycyrrhiza inflata Batalin
(Fabaceae), which has been used as traditional medicine
since ancient times. In particular, licorice was used as a
medical raw material for multiple purposes such as anti-
dote, antitussive expectorant, relaxant, to relieve pain
that occurs because of a sudden nervous breakdown of
muscle or tissue, to reduce weight gain, to increase white
blood cell count, and also because of its diuretic and
anti-inflammatory effects [1]. Although licorice has been
used in both Eastern and Western medicine to treat a
wide variety of diseases from common cold to liver dis-
ease, more scientific evidence is needed to prove its po-
tential preventive and therapeutic benefits. The
biologically active components of licorice are liquiritins
(LQ), liquiritigenin (LG), glycyrrhizic acids (GAs), and
flavones (Fig. 1). Various biological effects of these com-
pounds and pharmacokinetics of glycyrrhizic acid have
been reported [2–4]. In addition, studies have been per-
formed to analyze and characterize primary and second-
ary metabolites of licorice [5, 6].
Accumulating lines of evidence show that licorice has
anti-inflammatory, anticancer, antioxidant, and anti-
microbial effects [1, 4, 7–9]. In particular, recent studies
on hepatoprotective effects of licorice suggest that it can
reduce liver injury by enhancing antioxidant and anti-
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inflammatory capacity [7, 10]. Administration of licorice
extract prevented CCl4-induced hepatotoxicity by in-
creasing antioxidant enzyme activity and decreasing
TNF-α production [11]. Jung et al. [12] investigated the
hepatoprotective effects of 18β-glycyrrhetinic acid, one
of the active compounds in licorice, in a CCl4-induced
liver injury model. Treatment with 18β-glycyrrhetinic
acid inhibited the increase in serum alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST) ac-
tivities and hepatic lipid peroxidation in a dose-
dependent manner. In addition, 18β-glycyrrhetinic acid
significantly protected against glutathione (GSH) deple-
tion. Although these studies show a promising effect of
licorice in preventing liver injury, their limitation was
that the chemically induced acute hepatotoxicity model
used was not very relevant to clinical situations.
Alcohol abuse causes a range of acute and chronic
health problems worldwide, which lead to morbidity and
mortality. Depending on overall alcohol consumption and
drinking patterns, chronic exposure to alcohol is harmful
to the central nervous system and many organs, including
the liver. Among alcohol-induced liver diseases, fatty liver
is the most common histopathologic condition in
drinkers. Although alcohol-induced fatty liver is widely
considered to be benign and to have a very low risk of
progression, clinical studies have provided evidence that it
is an important pathogenic factor in the development of
liver disease [13–15]. Specifically, the authors suggested
that both oxidative stress and inflammation as second hits
are critical factors in the pathological progression from
simple fat accumulation to liver disease. Recently, we re-
ported that licorice extract had an anti-inflammatory ef-
fect in lipopolysaccharide-stimulated microglial cells and
acted as an antioxidant in a tert-butyl hydroperoxide–in-
duced oxidative liver injury model [16]. Therefore, it was
of interest to examine the effects of licorice on chronic
alcohol-induced fatty liver, which is more relevant to clin-
ical situations. In this study, we examined the preventive
effect of licorice in alcoholic fatty liver by administering
its extract to mice exposed to alcohol for 4 weeks.
Methods
Extraction
Glycyrrhiza uralensis Fisher (Fabaceae) was cultivated
in Jecheon, Chungbuk Province, Korea. The raw ma-
terial has been provided by the Korea Licorice Farm-
ing Association in 2013 and its extraction was
produced by Tecos Co., Ltd (Chuncheon, Korea).
Prof. Min Hye Yang of the Pusan National University
identified plant material and a voucher specimen
(PNU-0020) has been deposited in the Medicinal
Herb Garden, Pusan National University (Busan,
Korea). The analysis of biological component and
microbiological test were confirmed by Novarex Co.,
Ltd (Ochang, Korea). All other chemicals were pur-
chased from Sigma Chemical Co. (St. Louis, MO,
Fig. 1 Structures of Liquiritins (1 ~ 4), Glycyrrhizic acids (5 ~ 6), and Flavones (7 ~ 11) in licorice
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USA) and Wako Pure Chemical Industries (Osaka,
Japan). The raw material of licorice (the root of Gly-
cyrrhiza uralensis Fisher, 400 kg) was extracted for
3 h using a reflux circulation of 70 % aqueous etha-
nol (2800 L). The extracts was cooled at 30 ~ 35 °C
and filtered using 75 μm cartridge and then the resi-
due of raw materials was removed through subject of
a centrifuge. The residue was concentrated in vacuo
under reduced pressure (10 atm, 55 ~ 58 °C) to reach
10 ~ 20 brix materials (52 ~ 64 kg). The residue was
blended with dextrin and sterilized at 95 °C for
30 min and then it was spray-dried (liquid
temperature: 75 ~ 80 °C, the blowing temperature of
180 °C, atomizer 18,000 rpm) to provide a licorice ex-
tract powder (90 kg, 11.3 %). To establish bulk scale
production of licorice extracts, we confirmed manu-
facturing process based on experimental pilot condi-
tion using Jecheon domestic licorice in Korea (Fig. 2).
Analysis of licorice extract
To confirm two index components such as triterpenoid
saponin series GA and flavonoids LQ, we performed
quantitative and qualitative analysis through HPLC and
HPLC-MS/MS based on United States Pharmacopoeia
and Korean Pharmacopeia as standard analytical
methods (Fig. 3).
Analytical condition of LC-MS/MS
We used digoxin as internal standard in order to quanti-
tative analysis of major components GA, LQ, and LG of
licorice extract. In addition, we performed material sep-
aration for each component of the material using LUNA
C18 column (2.0 × 150 mm, 5 μm). Solvent A was water
with 1.0 % acetic acid and solvent B was acetonitrile with
1.0 % acetic acid. The gradients of solvents were as fol-
lowings: 0 min, 10 % B; 1 min, 10 % B; 6.5 min, 90 % B;
8 min, 90 % B; 8.5 min, 10 % B; 15 min, 10 % B. Samples
were dissolved in 50 % acetonitrile and the injection vol-
ume of each sample was 5 μl. Detailed condition for LC-
MS/MS analysis is in the Table 1.
Animals and treatments
Male C57BL/6 mice were purchased from Orient Bio
(Sungnam, Korea). The use of animals was in compli-
ance with the guidelines established and approved by the
Institutional Animal Care and Use Committee in Pusan
National University (PNU-2014-0568). Animals were ac-
climated to temperature (22 ± 2 °C) and humidity (55 ±
5 %) controlled rooms with a 12-h light/dark cycle for
1 week prior to use. The diets were purchased from
Dyets Inc. (Bethlehem, PA, USA). Mice were fed a Lie-
ber–DeCarli liquid diet with or without ethanol for
4 week. For the control liquid diet, 35 % of energy was
derived from fat, 18 % from protein, and 47 % from car-
bohydrates; the liquid ethanol diet contained 35 % of en-
ergy from fat, 18 % from protein, 11 % from
carbohydrates, and 36 % from ethanol.
Serum biochemistry and histopathologic evaluation
Serum levels of alanine aminotransferase (ALT), aspar-
tate aminotransferase (AST), total serum triglyceride
(TG) were measured using Automated Chemistry
Analyzer (Prestige 24I; Tokyo Boeki Medical System,
Tokyo, Japan). For histopathologic evaluation, a cross
section of the left lateral lobe of the liver was sliced at
10 μm, immersed in propylene glycol for 5 min, and
Fig. 2 Manufacture process for production of licorice extracted powder
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stained with Oil red O for 7 min. After rinsing with
85 % propylene glycol and distilled water, the sections
were counterstained with hematoxylin for 2 min before
microscopic examination.
Measurement of serum TNF-α
The levels of serum TNF-α were determined by enzyme-
linked immunosorbent assay using a commercially avail-
able kit (R&D Systems, Minneapolis, MN) according to
the manufacturer’s instruction.
Determination of hepatic triglyceride contents
Total lipids of the liver were extracted from homogenate
prepared from 100 mg of mouse liver using the mixture of
chloroform/methanol (2:1, v/v). Triglycerides in total lipid
were determined enzymatically using a commercially
available enzymatic kit (Sigma Chemical Co.) according to
the manufacturer’s protocol.
Measurement of hepatic glutathione (GSH)
Liver was homogenized in a four-fold volume of ice-cold
1 M perchloric acid. After the denatured protein was re-
moved by centrifugation at 10,000 g for 10 min, the super-
natant was assayed for the total GSH concentration using
a HPLC separation/fluorometric detection method [17].
Real time RT-PCR
Total RNA was purified from liver tissue using the
RNeasy kit (Qiagen, Valencia, CA, USA). cDNA synthe-
sis was accomplished with iScript™ cDNA Synthesis sys-
tem (Bio-Rad, Hercules, CA, USA). Real time RT-PCR
was performed using Thunderbird SYBR qPCR mix
m/z m/z
m/z m/z
Fig. 3 LC-MS/MS spectrum of standard (a) and licorice extract (b)
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(Toyobo Co., Ltd., Osaka, Japan) according to the manu-
facturer’s protocol. Relative values of gene expression
were normalized to 18S ribosomal RNA. Primer se-
quences and full name of the genes are provided in
Additional file 1: Table S1.
Statistical analysis
All results expressed as mean ± s.d. were analyzed by
one-way analysis of variance (ANOVA) followed by
Newman-Keuls multiple range test (parametric). The ac-
ceptable level of significance was established at P < 0.05.
Results
We analyzed licorice extract composition based on testing
condition using a Shiseido HPLC system coupled to an
AB Sciex electrospray-ionization (ESI) mass-spectrometer
(Table 2). For quantitative LC-MS/MS analysis of each
component, we established optimal conditions for the pre-
cursor ion and product ion by adjusting collision energy,
cone voltage, and cone temperature of the ion source
(Table 1). The instrument was operated in the multiple-
reaction-monitoring (MRM) mode.
We prepared the calibration curves for GA, LQ, and
LG according to the concentration-dependent ESI
method in LC-MS/MS analysis. We found that the cor-
relation coefficient (r2) values were 0.9999, 0.9997, and
0.9998, respectively, which showed good linearity of the
calibration curves (Table 2). The limit of detection
(LOD) was 4.29 ng/mL, 1.27 ng/mL, and 0.54 ng/mL,
whereas the limit of quantitation (LOQ) was 13.99 ng/
mL, 3.86 ng/mL, and 1.64 ng/mL, respectively.
We performed quantitative analysis of GA, LQ, and LG.
The MRM conditions were m/z 821.4 (precursor ion)→
351.0 (product ion) for GA, m/z 417.1 (precursor ion)→
255.0 (product ion) for LQ, and m/z 255.0 (precursor
ion)→ 119.0 (product ion) for LG. We set up the amount
of digoxin as internal standard at m/z 779.4 (precursor
ion)→ 649.4 (product ion). For quantitative analysis, we
used the calibration curves to calculate the ratios of com-
pounds in the analyzed material to respective standards.
We diluted licorice extract 1/20 to ensure that the con-
centrations of its components are within the quantitative
ranges of the calibration curves, and then multiplied the
obtained concentrations by 20 (the dilution factor). The
results of quantitation of the licorice extract components
were as follows: GA, 15.77 ± 0.34 μg/mg; LQ, 14.55 ±
0.42 μg/mg; and LG, 1.34 ± 0.02 μg/mg (Table 3).
To test the effect of licorice on alcohol-induced fatty
liver, a dose-dependence study was performed in mice fed
a standard Lieber–DeCarli liquid diet supplemented with
ethanol for 4 weeks (Fig. 4). Different dosage of licorice
ranging from 25 mg/kg body weight to 200 mg/kg body
weight was orally administered every day from the begin-
ning of the liquid diet. At the end of the treatment period,
lipid accumulation in the liver was evaluated by Oil Red-O
staining (Fig. 4a). Serum ALT and AST activities were also
determined (Fig. 4b and c). The dose of 25 to 50 mg/kg
body weight was not effective, but treatment with doses ex-
ceeding 100 mg/kg significantly reversed hepatic lipid ac-
cumulation and serum ALT, AST activities (Fig. 4).
We compared the effect of licorice (100 mg/kg body
weight) on alcoholic fatty liver with that of silymarin
(100 mg/kg body weight; Sigma Chemical Co., Cat
S0292), which is a well-known compound that alleviates
alcohol-induced liver injury. Using staining with Oil
Red-O and evaluation of hepatic triglyceride, we found
Table 1 Condition for LC-MS/MS analysis of Licorice extracts
A.
HPLC Condition
Column Luna C18 RP column (2.0 × 150 mm, 5 μm)
Flow rate 0.3 mL/min
Injection volume 5 μL
Column temperature 40 °C
Autosampler temperature 4 °C
B.
Mass condition
Ion source Turbo spray (Negative)
Curtain Gas 30 psi
Collision Gas N2 (Medium)
Ionspray Voltage - 4.0 kV
Source temperature 400 °C
Gas 1 40 psi
Gas 2 50 psi
Table 2 Linearities, regression equation, correlation coefficients, limit of detection (LOD), and limit of quantitation (LOQ) for
glycryrrhizic acid (GA), liquiritin (LQ) and liquiritigenin (LG)
Compounds Linear range (ng/ml) Regression equationa Correlation coefficient LODb (ng/ml) LOQc (ng/ml)
Glycyrrhizic acid (GA) 12.5–5000 Y = 0.0004x – 0.0055 0.9999 4.62 13.99
Liquiritin (LQ) 12.5–1000 Y = 0.0059x + 0.0451 0.9997 1.27 3.86
Liquiritigenin (LG) 12.5–500 Y = 0.0289x + 0.1574 0.9998 0.54 1.64
ay: Analyte area / IS area; x: concentration (ng/mL) of compounds
bLOD = 3.3 x δ /S (δ; standard deviation, S; slope of the calibration curve)
cLOQ = 10 x δ /S (δ; standard deviation, S; slope of the calibration curve)
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Table 3 Analytical LC-MS/MS data of licorice extracts
Compounds Peak area IS area Analytes/IS ratio Calculation μg/mg Ave. S.D.
Glycyrrhizic Acid (GA) 1/20 dil.1 23,132 74,555 0.31 789.42 15.79 15.77 0.34
1/20 dil.2 23,226 73,402 0.32 804.80 16.10
1/20 dil.3 23,016 75,956 0.30 771.29 15.43
Liquiritin (LQ) 1/20 dil.1 316,205 74,555 4.24 711.21 14.22 14.55 0.42
1/20 dil.2 328,810 73,402 4.48 751.61 15.03
1/20 dil.3 326,100 75,956 4.29 720.03 14.40
Liquiritigenin (LG) 1/20 dil.1 153,592 74,555 2.06 65.84 1.32 1.34 0.02
1/20 dil.2 154,374 73,402 2.10 67.33 1.35
1/20 dil.3 159,391 75,956 2.10 67.16 1.34
Fig. 4 Dose-dependence study of licorice in alcohol-induced fatty liver. Hepatic lipid accumulation (a), serum ALT (b) and AST (c) activities in mice
fed different diet with or without licorice. The livers were stained with Oil red O for histopathological examination. Each value represents the
mean ± SD for 6 mice. Values with different letters are significantly different from one another (ANOVA followed by Newman-Keuls multiple range
test P < 0.05)
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that licorice was a promising candidate to alleviate alco-
holic fatty liver in comparison with the inhibitory effect
of silymarin on fat accumulation induced by chronic al-
cohol ingestion (Fig. 5a and b).
Biochemical analyses of serum ALT, AST activities,
and liver triglyceride levels corresponded to the his-
topathologic findings: licorice administration signifi-
cantly attenuated the effects of ethanol on
triglyceride accumulation in the liver and ALT and
AST activities in serum (Fig. 5c and d). The hepatic
GSH content in ethanol-treated mice was signifi-
cantly lower than that in the control mice. Licorice
treatment restored GSH to its original level (Fig. 6a).
Licorice also significantly decreased the level of
serum TNF-α (Fig. 6b).
To find detailed mechanism for the hepatic lipid
lowering effect of licorice, we analyzed the hepatic ex-
pression levels of the lipogenic genes such as Srebf1
and Fasn, and the genes involved in lipid transporta-
tion such as Mttp, Apob, Cd36, Lpl, Ldlr, Fatp1,
Fatp2, Fatp3, Fatp4, and Fatp5 (Fig. 7). Chronic alco-
hol drinking significantly enhanced Srebf1 expression
and the mRNA level of Cd36 and Lpl, Fatp4 related
to lipid uptake. However, licorice supplement signifi-
cantly prevented the induction of these genes
expression.
Discussion
Although the mechanisms of the induction of fatty
liver by alcohol appear to be complicated, accumulat-
ing lines of evidence suggest contribution of both oxi-
dative stress and inflammation. On the basis of our
recent findings that licorice protects cells against in-
flammation and oxidative stress [16], we hypothesized
that licorice would alleviate alcohol-induced fatty liver
injury.
In mice fed a standard Lieber–DeCarli alcohol diet for
4 weeks, hepatic triglyceride levels increased and GSH
content decreased with concomitant increases in serum
ALT and AST activities, triglycerides, and TNF-α. Sup-
plementation of the alcohol diet with licorice for the
same time period significantly reversed the changes in
liver injury markers and effectively abrogated fat accu-
mulation. Thus, we suggest that the hepatoprotective
Fig. 5 Effect of licorice on hepatic lipid accumulation and serum ALT, AST compared with silymarin as a positive control. Hepatic lipid
accumulation (a) and triglyceride level (b), serum ALT (c) and AST (d) activities in mice fed different diet with or without licorice. The livers were
stained with Oil red O for histopathological examination. Each value represents the mean ± SD for 6 mice. Values with different letters are
significantly different from one another (ANOVA followed by Newman-Keuls multiple range test P < 0.05)
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Fig. 7 Effect of licorice on the level of hepatic mRNA expression in alcohol-induced fatty liver. mRNA expression of Srebf1 and Fasn for
lipogenesis, and Mttp and Apob for lipid export in the liver (a). Expression of mRNA related to lipid uptake in the liver (b). Each value represents
the mean ± SD for 6 mice. Values with different letters are significantly different from one another (ANOVA followed by Newman-Keuls multiple
range test P < 0.05)
Fig. 6 Effect of licorice on the level of hepatic GSH (a) and serum TNFα (b) in alcohol-induced fatty liver. Each value represents the mean ±SD for
6 mice. Values with different letters are significantly different from one another (ANOVA followed by Newman-Keuls multiple range test P < 0.05)
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effect of licorice is associated with an augmentation of
antioxidant defense and anti-inflammatory response.
GSH, a thiol-containing tripeptide, plays a major anti-
oxidant and detoxification role in the liver. Alcohol in-
creases the levels of intracellular reactive oxygen species
and depletes mitochondrial GSH, and therefore induces
oxidative stress [18]. Although the contribution of oxida-
tive injury to the development of alcoholic fatty liver re-
mains to be elucidated, enhancement of antioxidant
capacity using some compounds ameliorates alcoholic
fatty liver [19–22]. In line with these results, overexpres-
sion of superoxide dismutase prevents the accumulation
of lipid droplets in hepatocytes, whereas double knock-
out of glutathione peroxidase-1 and catalase aggravates
alcohol-induced liver injury [23–25]. Our results thus in-
dicate that an improvement in the antioxidant capacity
in alcohol-fed mice via recovery of the hepatic GSH pool
could make licorice valuable in the treatment of alco-
holic liver disease.
Direct inflammatory and cytotoxic effects of TNF-α in
alcoholic liver disease are well characterized. Chronic
drinking of alcohol increases the level of bacterial endo-
toxin, which stimulates resident liver macrophages to
produce free radicals and cytokines [26]. NADPH oxi-
dase plays critical roles in the generation of oxidants in
resident liver macrophages after alcohol intake. Activa-
tion of NF-kB by oxidant generation leads to an increase
in the TNF-α level, which causes tissue injury [27].
Moreover, TNF-α is suggested to induce lipolysis in adi-
pose tissue followed eventually by fatty liver. Earlier
studies showed that TNF-α causes free fatty acid release
from adipocytes, stimulates lipogenesis in the liver, and
inhibits β-oxidation of free fatty acids [28–30]. More-
over, in a more recent report, TNF-α was suggested to
increase intrahepatic fat deposition by affecting hepatic
lipogenic metabolism that involves SREBP-1c [31]. In-
deed, TNFR1 knockout almost completely blocks the de-
velopment of alcohol-induced fatty liver [32] . In
agreement with these reports, the present study demon-
strated that licorice significantly inhibited up-regulation
of Srebf1 by chronic alcohol drinking. Importantly, in-
crease of gene expression involved in lipid uptake such
as Cd36, Lpl, and Fatp4 is also effectively reduced by lic-
orice treatment. Considering the importance of TNF-α
in the development of alcoholic fatty liver, suppression
of TNF-α secretion by licorice may contribute to its
overall preventive effect in alcoholic liver injury.
Conclusion
We found that licorice is effective in preventing alco-
holic fatty liver in mice. An important issue in the man-
agement of alcoholic liver disease is the progression of
simple fat accumulation to alcoholic hepatitis. Licorice
treatment restored hepatic GSH content and inhibited
TNF-α secretion, and also inhibited lipid accumulation
in the liver of chronic alcohol-fed mice. Therefore, lic-
orice is a promising candidate to prevent the progression
of alcoholic liver injury, which probably acts by enhan-
cing anti-oxidative and anti-inflammatory capacity.
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